Document/ExhibitDescriptionPagesSize 1: 10-Q Quarterly Report HTML 1.39M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 32K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 32K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 26K
11: R1 Cover Page HTML 76K
12: R2 Condensed Consolidated Balance Sheets HTML 152K
13: R3 Condensed Consolidated Balance Sheets HTML 49K
(Parenthetical)
14: R4 Condensed Consolidated Statements of Operations HTML 122K
15: R5 Condensed Consolidated Statements of Comprehensive HTML 73K
Income
16: R6 Condensed Consolidated Statements of Stockholders' HTML 82K
Equity
17: R7 Condensed Consolidated Statements of Cash Flows HTML 84K
18: R8 Basis of Presentation HTML 27K
19: R9 Trade Accounts Receivable Sale Programs HTML 67K
20: R10 Inventories HTML 33K
21: R11 Leases HTML 54K
22: R12 Notes Payable and Long-Term Debt HTML 51K
23: R13 Asset-Backed Securitization Program HTML 67K
24: R14 Accrued Expenses HTML 35K
25: R15 Postretirement and Other Employee Benefits HTML 51K
26: R16 Derivative Financial Instruments and Hedging HTML 49K
Activities
27: R17 Accumulated Other Comprehensive Income HTML 65K
28: R18 Stockholders' Equity HTML 61K
29: R19 Concentration of Risk and Segment Data HTML 99K
30: R20 Restructuring, Severance and Related Charges HTML 44K
31: R21 Income Taxes HTML 37K
32: R22 Earnings Per Share and Dividends HTML 45K
33: R23 Fair Value Measurements HTML 77K
34: R24 Commitments and Contingencies HTML 27K
35: R25 New Accounting Guidance HTML 36K
36: R26 New Accounting Guidance (Policies) HTML 26K
37: R27 Trade Accounts Receivable Sale Programs (Tables) HTML 38K
38: R28 Inventories (Tables) HTML 34K
39: R29 Leases (Tables) HTML 48K
40: R30 Notes Payable and Long-Term Debt (Tables) HTML 45K
41: R31 Asset-Backed Securitization Program (Tables) HTML 39K
42: R32 Accrued Expenses (Tables) HTML 34K
43: R33 Postretirement and Other Employee Benefits HTML 47K
(Tables)
44: R34 Derivative Financial Instruments and Hedging HTML 46K
Activities (Tables)
45: R35 Accumulated Other Comprehensive Income (Tables) HTML 67K
46: R36 Stockholders' Equity (Tables) HTML 65K
47: R37 Concentration of Risk and Segment Data (Tables) HTML 94K
48: R38 Restructuring, Severance and Related Charges HTML 43K
(Tables)
49: R39 Income Taxes (Tables) HTML 33K
50: R40 Earnings Per Share and Dividends (Tables) HTML 46K
51: R41 Fair Value Measurements (Tables) HTML 77K
52: R42 Trade Accounts Receivable Sale Programs - HTML 35K
Additional Information (Details)
53: R43 Trade Accounts Receivable Sale Programs - Trade HTML 32K
Accounts Receivable Sale Programs Amounts
Recognized (Details)
54: R44 Inventories (Details) HTML 35K
55: R45 Leases - Future Minimum Lease Payments under HTML 50K
Operating and Finance Leases (Details)
56: R46 Notes Payable and Long-Term Debt - Schedule of HTML 68K
Notes Payable and Long-term Debt (Details)
57: R47 Notes Payable and Long-Term Debt - Additional HTML 38K
Information (Details)
58: R48 Asset-Backed Securitization Program - Additional HTML 27K
Information (Details)
59: R49 Asset-Backed Securitization Program - HTML 33K
Securitization Activity (Details)
60: R50 Accrued Expenses (Details) HTML 37K
61: R51 Postretirement and Other Employee Benefits HTML 48K
(Details)
62: R52 Derivative Financial Instruments and Hedging HTML 33K
Activities - Additional Information (Details)
63: R53 Derivative Financial Instruments and Hedging HTML 32K
Activities - Fair Value of Derivative Instruments
Recorded on Consolidated Statements of Operations
(Details)
64: R54 Derivative Financial Instruments and Hedging HTML 33K
Activities - Cash Flow Hedges (Details)
65: R55 Accumulated Other Comprehensive Income - Change in HTML 69K
AOCI, Net of Tax (Details)
66: R56 Accumulated Other Comprehensive Income - HTML 61K
Reclassification from AOCI (Details)
67: R57 Stockholders' Equity - Recognized Stock-Based HTML 31K
Compensation (Details)
68: R58 Stockholders' Equity - Additional Information HTML 45K
(Details)
69: R59 Stockholders' Equity - Stock-based Compensation HTML 29K
Information (Details)
70: R60 Stockholders' Equity - Common Stock Outstanding HTML 59K
(Details)
71: R61 Concentration of Risk and Segment Data - HTML 35K
Additional Information (Details)
72: R62 Concentration of Risk and Segment Data - Segment HTML 60K
Income (Details)
73: R63 Concentration of Risk and Segment Data - Revenues HTML 44K
Disaggregated by Segment (Details)
74: R64 Concentration of Risk and Segment Data - Foreign HTML 31K
Source Revenue (Details)
75: R65 Restructuring, Severance and Related Charges HTML 47K
(Details)
76: R66 Income Taxes - Schedule of U.S. Federal Statutory HTML 29K
Income Tax Rate Compared to Actual Income Tax
Expense (Details)
77: R67 Income Taxes - Additional Information (Details) HTML 26K
78: R68 Earnings Per Share and Dividends - Earnings Per HTML 29K
Share (Details)
79: R69 Earnings Per Share and Dividends - Cash Dividends HTML 29K
Declared by the Company to Common Stockholders
(Details)
80: R70 Fair Value Measurements - Fair Value Measurements HTML 47K
on a Recurring Basis (Details)
81: R71 Fair Value Measurements - Fair Value of Financial HTML 65K
Instruments (Details)
84: XML IDEA XML File -- Filing Summary XML 157K
82: XML XBRL Instance -- d391318d10q_htm XML 1.74M
83: EXCEL IDEA Workbook of Financial Reports XLSX 125K
7: EX-101.CAL XBRL Calculations -- jbl-20230228_cal XML 170K
8: EX-101.DEF XBRL Definitions -- jbl-20230228_def XML 499K
9: EX-101.LAB XBRL Labels -- jbl-20230228_lab XML 1.33M
10: EX-101.PRE XBRL Presentations -- jbl-20230228_pre XML 828K
6: EX-101.SCH XBRL Schema -- jbl-20230228 XSD 144K
85: JSON XBRL Instance as JSON Data -- MetaLinks 425± 646K
86: ZIP XBRL Zipped Folder -- 0001193125-23-091542-xbrl Zip 303K
(Exact name of registrant as specified in its charter)
iDelaware
i38-1886260
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
i10800 Roosevelt Boulevard North, iSt. Petersburg, iFloridai33716
(Address of principal executive offices) (Zip Code)
(i727) i577-9749
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
iCommon Stock, $0.001 par value per share
iJBL
iNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. iYes☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). iYes☒ No ☐
Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,”“accelerated filer,”“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
iLarge accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
i☐
Emerging growth company
i☐
1
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No i☒
Current installments of notes payable and long-term debt
$
i323
$
i300
Accounts payable
i6,965
i8,006
Accrued expenses
i5,866
i5,272
Current operating lease liabilities
i128
i119
Total current liabilities
i13,282
i13,697
Notes payable and long-term debt, less current installments
i2,577
i2,575
Other liabilities
i297
i272
Non-current operating lease liabilities
i405
i417
Income tax liabilities
i206
i182
Deferred income taxes
i126
i122
Total liabilities
i16,893
i17,265
Commitments and contingencies
i
i
Equity:
Jabil Inc. stockholders’ equity:
Preferred stock, $ii0.001/
par value, authorized ii10,000,000/
shares; iino/ shares issued and iino/
shares outstanding
i—
i—
Common stock, $ii0.001/
par value, authorized ii500,000,000/ shares;
i273,531,447 and i270,891,715 shares issued and i133,238,368
and i135,493,980 shares outstanding as of February 28, 2023 and August 31, 2022, respectively
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1.
iBasis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal
recurring accruals) necessary to present fairly the information set forth therein have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in the Annual Report on Form 10-K of Jabil Inc. (the “Company”) for the fiscal year ended August 31, 2022. Results for the six months ended February 28, 2023 are not necessarily an indication of the results that may be expected for the full fiscal year ending August 31, 2023.
2. iTrade
Accounts Receivable Sale Programs
The Company regularly sells designated pools of high credit quality trade accounts receivable, at a discount, under uncommitted trade accounts receivable sale programs to unaffiliated financial institutions without recourse. As these accounts receivable are sold without recourse, the Company does not retain the associated risks following the transfer of such accounts receivable to the respective financial institutions.
As of February 28, 2023, the Company may elect to sell receivables and the unaffiliated financial institutions may elect to purchase specific accounts receivable
at any one time up to a: (i) maximum aggregate amount available of $i2.1 billion under inine
trade accounts receivable sale programs, (ii) maximum amount available of i400 million CNY under ione
trade accounts receivable sale program and (iii) maximum amount available of i100 million CHF under ione
trade accounts receivable sale program. The trade accounts receivable sale programs expire on various dates through 2025.
The Company continues servicing the receivables sold and in exchange receives a servicing fee under each of the trade accounts receivable sale programs. Servicing fees related to the trade accounts receivable sale programs recognized during the three months and six months ended February 28, 2023 and 2022 were not material. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that
the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities.
i
In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions):
(1)Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows.
(2)Recorded to other expense within the Condensed Consolidated Statements of Operations.
/
3. iInventories
i
Inventories
consist of the following (in millions):
During
fiscal year 2023, the Company entered into new operating and finance leases. iiThe
future minimum lease payments under these new leases as of February 28, 2023 were as follows (in millions):/
Payments due by period
Total
Less than 1 year
1-3 years
3-5 years
After 5 years
Operating lease obligations(1)
$
ii70/
$
ii19/
$
ii29/
$
ii17/
$
ii5/
Finance lease obligations(1)
$
ii75/
$
ii45/
$
ii30/
$
ii—/
$
ii—/
(1)Excludes $i204 million of payments related to operating and finance leases signed but not yet commenced. Of these excluded payments, $i122 million
relates to a variable interest entity (“VIE”), for which the Company is not the primary beneficiary. This is also the Company’s maximum exposure to loss related to the VIE. The Company expects the lease related to the VIE to commence in fiscal year 2024. Additionally, certain leases signed but not yet commenced contain residual value guarantees and purchase options not deemed probable.
Less current installments of notes payable and long-term debt
i323
i300
Notes payable and long-term debt, less current installments
$
i2,577
$
i2,575
(1)On February 10, 2023, the Company entered into an amendment (the “Amendment”) to its senior unsecured credit agreement dated as of January 22, 2020 (as amended, the “Credit Facility”). The Amendment, among other things, (i) instituted certain amendments to the sustainability-linked adjustments to the interest rates applicable to borrowings under the ithree-year
revolving credit facility (the “iThree-Year Revolving Credit Facility”) and the Company’s ifive-year revolving credit facility (the “iFive-Year
Revolving Credit Facility”), (ii) established customary SOFR, CDOR, EURIBOR and TIBOR provisions, which replaced the LIBOR provisions set forth in the existing agreement, and (iii) extended the termination date of the iThree-Year Revolving Credit Facility to January 22, 2025, and of the iFive-Year
Revolving Credit Facility to January 22, 2027.
(2)As of February 28, 2023, the Company has $i3.8 billion in available unused borrowing capacity under its revolving credit facilities. The Credit Facility acts as the back-up facility for commercial paper outstanding, if any. The
Company has a borrowing capacity of up to $i3.2 billion under its commercial paper program.
/
Debt Covenants
Borrowings under the Company’s debt agreements are subject to various covenants that limit the
Company’s ability to: incur additional indebtedness, sell assets, effect mergers and certain transactions, and effect certain transactions with subsidiaries and affiliates. In addition, the revolving credit facilities and the i4.900% Senior Notes contain debt leverage and interest coverage covenants. The Company is also subject to certain covenants requiring the
Company to offer to repurchase the i4.900%, i3.950%, i3.600%,
i3.000%, i1.700% or i4.250%
Senior Notes upon a change of control. As of February 28, 2023 and August 31, 2022, the Company was in compliance with its debt covenants.
Refer to Note 16 – “Fair Value Measurements” for the estimated fair values of the Company’s
notes payable and long-term debt.
6. Asset-Backed Securitization Program
Certain Jabil entities participating in the global asset-backed securitization program continuously sell designated pools of trade accounts receivable to a special purpose entity, which in turn sells certain of the receivables at a discount to conduits administered by an unaffiliated financial institution on a monthly basis. In addition, a foreign entity participating in the global asset-backed securitization program sells certain receivables at a discount to conduits administered by an unaffiliated financial institution on a daily basis.
The Company continues servicing
the receivables sold and in exchange receives a servicing fee under the global asset-backed securitization program. Servicing fees related to the global asset-backed securitization program recognized during the three months and six months ended February 28, 2023 and 2022 were not material. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities.
The special purpose entity in the global asset-backed securitization program is a wholly-owned subsidiary of the
Company and is included in the Company’s Condensed Consolidated Financial Statements. Certain unsold receivables covering up to the maximum amount of net cash proceeds available under the domestic, or U.S., portion of the global asset-backed securitization program are pledged as collateral to the unaffiliated financial institution as of February 28, 2023.
The global asset-backed securitization program expires on November 25, 2024 and the maximum amount of net cash proceeds available at any one time is $i600
million. As of February 28, 2023, the Company had ino available liquidity under its global asset-backed securitization program.
i
In
connection with the asset-backed securitization programs, the Company recognized the following (in millions):
(1)Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows.
(2)The amounts primarily represent proceeds from collections reinvested in revolving-period transfers.
(3)Recorded to other expense within the Condensed Consolidated Statements of Operations.
/
The global asset-backed securitization program requires compliance with several covenants including compliance with
the interest ratio and debt to EBITDA ratio of the Credit Facility. As of February 28, 2023 and August 31, 2022, the Company was in compliance with all covenants under the global asset-backed securitization program.
7. iAccrued
Expenses
i
Accrued expenses consist of the following (in millions):
(1)Revenue recognized during the six months ended February 28, 2023 and 2022 that was included in the contract liability balance as of August 31, 2022and 2021was $i254
million and $i196 million, respectively.
The
following table provides information about the net periodic benefit cost for all plans for the three months and six months ended February 28, 2023 and 2022 (in millions):
(1)Service cost is recognized in cost of revenue in the Condensed Consolidated Statements of Operations.
(2)Components are recognized in other expense in the Condensed Consolidated Statements of Operations.
(3)Actuarial gains and losses are amortized using a corridor approach. The gain/loss corridor is equal to i10
percent of the greater of the projected benefit obligation and the fair value of plan assets. Gains and losses in excess of the corridor are generally amortized over the average future working lifetime of the plan participants.
/
9. iDerivative
Financial Instruments and Hedging Activities
The Company is directly and indirectly affected by changes in certain market conditions. These changes in market conditions may adversely impact the Company’s financial performance and are referred to as market risks. The Company, where deemed appropriate, uses derivatives as risk management tools to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative instruments are foreign currency risk and interest rate risk.
Foreign
Currency Risk Management
Forward contracts are put in place to manage the foreign currency risk associated with the anticipated foreign currency denominated revenues and expenses. A hedging relationship existed with an aggregate notional amount outstanding of $i1.0 billion and $i1.4
billion as of February 28, 2023 and August 31, 2022, respectively. The related forward foreign exchange contracts have been designated as hedging instruments and are accounted for as cash flow hedges. The forward foreign exchange contract transactions will effectively lock in the value of anticipated foreign currency denominated revenues and expenses against foreign currency fluctuations. The anticipated foreign currency denominated revenues and expenses being hedged are expected to occur between March 1, 2023 and November 30, 2023.
In addition to
derivatives that are designated as hedging instruments and qualify for hedge accounting, the Company also enters into forward contracts to economically hedge transactional exposure associated with commitments arising from trade accounts receivable, trade accounts payable, fixed purchase obligations and intercompany transactions denominated in a currency other than the functional currency of the respective operating entity. The aggregate notional amount of these outstanding contracts as of February 28, 2023 and August 31, 2022, was $i3.6
billion and $i3.4 billion, respectively.
The gains and losses recognized in earnings due to amounts excluded from effectiveness testing were not material for all periods presented and are included as components of net revenue, cost of revenue and selling, general and administrative expense, which are the same line items in which the hedged items are recorded.
In addition, the Company has entered into forward
foreign currency exchange contracts to hedge a portion of its net investment in foreign currency denominated operations, which are designated as net investment hedges. The net investment hedges have an aggregate notional amount outstanding of $i127 million and $i0
million as of February 28, 2023 and August 31, 2022, respectively, and are expected to mature in August 2023. The effective portion of the gain or loss on net investment hedges is reported in OCI to offset the change in the carrying value of the net investment being hedged until the complete or substantially complete liquidation of the hedged foreign operation. The excluded components for the net investment hedges are not material and are recognized in interest expense.
Refer to Note 16 – “Fair Value Measurements” for the fair values and classification of the Company’s derivative instruments.
The following table presents the net gains (losses) from forward contracts recorded in the Condensed Consolidated
Statements of Operations for the periods indicated (in millions):
Derivatives Not Designated as Hedging Instruments Under ASC 815
Location of Gain (Loss) on Derivatives Recognized in Net Income
Amount of Gain (Loss) Recognized in Net Income on Derivatives
(1)For the three months ended February 28, 2023, the Company recognized $i53 million of foreign currency losses in cost of revenue, which are offset by the gains from the forward foreign exchange contracts.
For the six months ended February 28, 2023, the Company recognized $i4 million of foreign currency losses in cost of revenue, in addition to losses from the forward foreign exchange contracts. For the three months and six months ended February
28, 2022, the Company recognized $i9 million and $i37
million, respectively, of foreign currency losses in cost of revenue, which are offset by the gains from the forward foreign exchange contracts.
Interest Rate Risk Management
The Company periodically enters into interest rate swaps to manage interest rate risk associated with the Company’s borrowings or anticipated debt issuances.
Cash Flow Hedges
i
The
following table presents the interest rate swaps outstanding as of February 28, 2023, which have been designated as hedging instruments and are accounted for as cash flow hedges (in millions):
(1)The contracts will be settled with the respective counterparties on a net basis at the expiration date for the forward interest rate swap.
(2)If the anticipated debt issuance occurs before July 31, 2024, the contracts will be terminated simultaneously with the debt issuance.
/
10.
iAccumulated Other Comprehensive Income
i
The following table sets forth the changes in accumulated other comprehensive income (“AOCI”),
net of tax, by component for the six months ended February 28, 2023 (in millions):
The
following table sets forth the amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, net of tax, for the periods indicated (in millions):
(1)The Company expects to reclassify less than $i1 million into earnings during the next twelve months, which will primarily be classified as a component of cost of revenue.
(2)Amounts are included in the computation of net periodic benefit
cost. Refer to Note 8 – “Postretirement and Other Employee Benefits” for additional information.
(3)Amounts are net of tax, which are immaterial for the three months and six months ended February 28, 2023 and 2022.
/
11. iStockholders’
Equity
i
The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions):
As of February 28, 2023, the shares available to be issued under the 2021 Equity Incentive Plan were i8,437,901.
Restricted
Stock Units
Certain key employees have been granted time-based, performance-based and market-based restricted stock unit awards (“restricted stock units”). The time-based restricted stock units generally vest on a graded vesting schedule over ithree years. The performance-based restricted stock units generally vest on a cliff vesting schedule over ithree
years and up to a maximum of i150%, depending on the specified performance condition and the level of achievement obtained. The performance-based restricted stock units have a vesting condition that is based upon the Company’s cumulative adjusted core earnings per share during the performance period. The market-based restricted stock units generally vest on
a cliff vesting schedule over ithree years and up to a maximum of i200%,
depending on the specified performance condition and the level of achievement obtained. The market-based restricted stock units have a vesting condition that is tied to the Company’s total shareholder return based on the Company’s stock performance in relation to the companies in the Standard and Poor’s (S&P) Super Composite Technology Hardware and Equipment Index excluding the Company. During the six months ended February 28, 2023 and 2022, the Company awarded approximately i0.9
million and i0.7 million time-based restricted stock units, respectively, i0.2
million and i0.2 million performance-based restricted stock units, respectively, and i0.2
million and i0.2 million market-based restricted stock units, respectively.
i
The
following represents the stock-based compensation information as of the period indicated (in millions):
Purchases of treasury stock under employee stock plans
(i47,242)
(i9,719)
(i570,649)
(i700,274)
Treasury shares purchased(1)(2)
(i1,723,744)
(i2,312,881)
(i4,324,695)
(i4,377,866)
Ending balances
i133,238,368
i142,392,135
i133,238,368
i142,392,135
(1)In July 2021, the Board of Directors approved an authorization for the repurchase of up to $i1.0 billion of the Company’s common stock (the “2022 Share Repurchase Program”). As of February 28, 2023, i16.5
million shares had been repurchased for $i1.0 billion and ino authorization remains
under the 2022 Share Repurchase Program.
(2)In September 2022, the Board of Directors approved an authorization for the repurchase of up to $i1.0 billion of the Company’s common stock (the “2023 Share Repurchase Program”). As of February 28, 2023, i0.3
million shares had been repurchased for $i25 million and $i975 million remains available
under the 2023 Share Repurchase Program.
/
12. iConcentration of Risk and Segment Data
Concentration of Risk
Sales of the
Company’s products are concentrated among specific customers. During the six months ended February 28, 2023, the Company’s five largest customers accounted for approximately i44% of its net revenue and 79 customers accounted for approximately i90%
of its net revenue. Sales to these customers were reported in the Electronics Manufacturing Services (“EMS”) and Diversified Manufacturing Services (“DMS”) operating segments.
The Company procures components from a broad group of suppliers. Some of the products manufactured by the Company require one or more components that are available from only a single source.
Segment Data
Net revenue for the operating segments is attributed to the segment in which the service is performed. An operating segment’s performance is evaluated based on its pre-tax operating contribution, or segment income. Segment income is defined as net revenue less cost of revenue, segment
selling, general and administrative expenses, segment research and development expenses and an allocation of corporate manufacturing expenses and selling, general and administrative expenses. Certain items are excluded from the calculation of segment income. Transactions between operating segments are generally recorded at amounts that approximate those at which we would transact with third parties.
The Company operates in more than i30 countries worldwide. Sales to unaffiliated customers are based on the Company location that maintains the customer relationship and transacts the external sale. iThe
following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue:
Total restructuring, severance and related charges(2)
$
i—
$
i—
$
i45
$
i—
(1)Primarily relates to headcount reduction to further optimize the Company’s business activities and includes $i0 million and $i4
million recorded in the EMS segment, $i0 million and $i33 million recorded in the DMS segment and $i0
million $i8 million of non-allocated charges for the three months and six months ended February 28, 2023, respectively. Except for asset write-off costs, all restructuring, severance and related charges are cash costs.
/
(2)The restructuring liability is $i34
million as of February 28, 2023, which primarily relates to employee severance and benefit costs incurred in fiscal year 2022 and the six months ended February 28, 2023.We expect the majority of the severance to be paid during fiscal year 2023.
14. iIncome Taxes
Effective
Income Tax Rate
i
The U.S. federal statutory income tax rate and the Company's effective income tax rate are as follows:
The effective income tax rate differed for the three months and six months ended February 28, 2023, compared to the three months and six months ended February 28, 2022, primarily due to: (i) a change in the jurisdictional mix of earnings, driven in part by restructuring charges for the six months ended February 28, 2023 and (ii) a $i10 million
income tax benefit associated with the reversal of a non-U.S. partial valuation allowance during the three months ended February 28, 2023.
The effective income tax rate differed from the U.S. federal statutory income tax rate of 21.0% during the three months and six months ended February 28, 2023 and 2022, primarily due to: (i) the jurisdictional mix of earnings, (ii) losses in tax jurisdictions with existing valuation allowances, and (iii) tax incentives granted to sites in China, Malaysia, Singapore and Vietnam.
15. iEarnings
Per Share and Dividends
Earnings Per Share
The Company calculates its basic earnings per share by dividing net income attributable to the Company by the weighted average number of common shares outstanding during the period. The Company’s diluted earnings per share is calculated in a similar manner, but includes the effect of dilutive securities. The difference between the weighted average number of basic shares outstanding and the weighted average number of diluted shares outstanding is primarily due to dilutive unvested restricted stock units.
Potential shares of common stock
are excluded from the computation of diluted earnings per share when their effect would be antidilutive. Performance-based restricted stock units are considered dilutive when the related performance criteria have been met assuming the end of the reporting period represents the end of the performance period. All potential shares of common stock are antidilutive in periods of net loss. iPotential shares of common stock not included in the computation of earnings per share
because their effect would have been antidilutive or because the performance criterion was not met were as follows (in thousands):
The following table sets forth cash dividends declared by the Company to common stockholders during the six months ended February 28, 2023 and 2022 (in millions, except for per share data):
The
following table presents the fair value of the Company's financial assets and liabilities measured at fair value by hierarchy level on a recurring basis as of the periods indicated (in millions):
Derivatives designated as hedging instruments (Note 9)
Level 2
(2)
$
i14
$
i32
Derivatives not designated as hedging instruments (Note 9)
Level 2
(2)
i27
i76
(1)Consist of investments that are readily convertible to cash with original maturities of 90 days or less.
(2)The Company’s forward foreign exchange contracts, including cash flow hedges and net investment hedges are measured on a recurring basis at fair value, based on foreign currency spot rates and forward rates quoted by banks or foreign currency dealers.
/
(3)Fair
value measurements are based on the contractual terms of the derivatives and use observable market-based inputs. The interest rate swaps are valued using a discounted cash flow analysis on the expected cash flows of each derivative using observable inputs including interest rate curves and credit spreads.
Fair Value of Financial Instruments
The carrying amounts of cash and cash equivalents, trade accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value because of the short-term nature of these financial instruments. The carrying amounts of borrowings under credit facilities and under loans approximates fair value as interest rates on these instruments approximates current market rates.
Notes payable and long-term debt is carried at amortized cost; however, the Company estimates the fair values of notes payable and long-term debt for disclosure purposes. iThe following table presents the carrying amounts and fair values of the
Company's notes payable and long-term debt, by hierarchy level as of the periods indicated (in millions):
(1)This fair value estimate is based on the Company’s indicative borrowing cost derived from discounted cash flows.
(2)The fair value estimates are based upon observable market data.
17. iCommitments
and Contingencies
Legal Proceedings
The Company is party to certain lawsuits in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s financial position, results of operations or cash flows.
18. iNew
Accounting Guidance
i
New accounting guidance adopted during the period did not have a material impact to the Company.
Recently issued accounting guidance is not applicable or did not have, or is not expected to have, a material impact to the Company.
This Quarterly Report on Form 10-Q contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Many of the forward-looking statements are located in Item 2 of this Form 10-Q under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking
statements can also be identified by words such as “future,”“anticipates,”“believes,”“estimates,”“expects,”“intends,”“plans,”“predicts,”“will,”“would,”“should,”“could,”“can,”“may,” and similar terms. Forward-looking statements are not guarantees of future performance and the Company’s actual results may differ significantly from the results discussed in the forward-looking statements. Achievement of anticipated results is subject to substantial risks, uncertainties and inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements, and
you are cautioned not to put undue reliance on forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. You are advised, however, to consult any further disclosures we make on related subjects. Factors that might cause such differences include, but are not limited to, those discussed in Part II, Item 1A to this Quarterly Report on Form 10-Q and in Part 1, Item 1A of the Company’s Annual Report on Form 10-K for the year ended August 31, 2022 such as, scheduling production, managing growth and capital expenditures and maximizing the efficiency of our manufacturing capacity effectively; managing rapid declines or increases in customer demand and other related
customer challenges that may occur; the scope and duration of the COVID-19 outbreak and its impact on our operations, sites, customers and supply chain; our dependence on a limited number of customers; our ability to purchase components efficiently and reliance on a limited number of suppliers for critical components; risks arising from relationships with emerging companies; changes in technology and competition in our industry; our ability to introduce new business models or programs requiring implementation of new competencies; competition; transportation issues; our ability to maintain our engineering, technological and manufacturing expertise; retaining key personnel; risks associated with international sales and operations; energy price increases or shortages; our ability to achieve expected profitability from acquisitions; risk arising from our restructuring activities; issues involving our information systems, including security issues; regulatory risks (including
the expense of complying, or failing to comply, with applicable regulations; risk arising from design or manufacturing defects; and intellectual property risk); financial risks (including customers or suppliers who become financially troubled; turmoil in financial markets; tax risks; credit rating risks; risks of exposure to debt; currency fluctuations; and asset impairment); changes in financial accounting standards or policies; and risk of natural disaster, climate change or other global events. References in this report to “the Company,”“Jabil,”“we,”“our,” or “us” mean Jabil Inc. together with its subsidiaries, except where the context otherwise requires.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Overview
We are one of the leading providers of worldwide manufacturing services and solutions. We provide comprehensive electronics design, production and product management services to companies in various industries and end markets. Our services enable our customers to reduce manufacturing costs, improve supply-chain management, reduce inventory obsolescence, lower transportation costs and reduce product fulfillment time. Our manufacturing and supply chain management services and solutions include innovation, design, planning, fabrication and assembly, delivery and managing the flow of resources and products. We derive
substantially all of our revenue from production and product management services (collectively referred to as “manufacturing services”), which encompass the act of producing tangible components that are built to customer specifications and are then provided to the customer.
We serve our customers primarily through dedicated business units that combine highly automated, continuous flow manufacturing with advanced electronic design and design for manufacturability. We currently depend, and expect to continue to depend for the foreseeable future, upon a relatively small number of customers for a significant percentage of our net revenue, which in turn depends upon their growth, viability and financial stability.
We conduct our operations in facilities that are located worldwide, including but not limited to, China, Ireland, Malaysia, Mexico, Singapore and the United States. We
derived a substantial majority, 84.0% and 85.0%, of net revenue from our international operations for the three months and six months ended February 28, 2023, respectively. Our global manufacturing production sites allow customers to manufacture products simultaneously in the optimal locations for their products. Our global presence is key to assessing and executing on our business opportunities.
We have two reporting segments: Electronics Manufacturing Services (“EMS”) and Diversified Manufacturing Services (“DMS”), which are organized based on the economic profiles of the services performed, including manufacturing capabilities, market strategy, margins, return on capital and risk profiles. Our EMS segment is focused around leveraging IT, supply chain design and engineering, technologies largely centered on core electronics, utilizing our large scale manufacturing
infrastructure and our ability to serve a broad range of end markets. Our EMS segment is a high volume business that produces product at a quicker rate (i.e. cycle time) and in larger quantities and includes customers primarily in the 5G, wireless and cloud, digital print and retail, industrial and semi-cap, and networking and storage industries. Our DMS segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies and healthcare. Our DMS segment includes customers primarily in the automotive and transportation, connected devices, healthcare and packaging, and mobility industries.
We monitor the current economic environment and its potential impact on both the customers we serve as well as our end-markets and closely manage our costs and capital resources so that we can respond appropriately as circumstances change.
Refer to Item 7. "Management's
Discussion and Analysis of Financial Condition and Results of Operations" section contained in our Annual Report on Form 10-K for the fiscal year ended August 31, 2022 for further discussion of the items disclosed in Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations" section as of February 28, 2023 contained herein.
COVID-19
The COVID-19 pandemic has had, and continues to have, significant impacts in countries where we operate. Travel and business operation restrictions arising from governmental virus containment efforts have continued to impact our operations in Asia during this fiscal year.
Certain of our suppliers continue to experience supply chain constraints, including difficulty
sourcing materials necessary to fulfill customer production requirements and challenges in transporting completed products to our end customers.
The following table sets forth, for the periods indicated, certain key operating results and other financial information (in millions, except per share data):
Management regularly reviews financial and non-financial performance indicators to assess the Company’s operating results. Changes in our operating assets and liabilities are largely affected by our working capital requirements, which are dependent on the effective management of our sales cycle as well as timing of payments. Our sales cycle measures how quickly we can convert our manufacturing services into cash through sales. We believe the metrics set forth below are useful to investors in measuring our liquidity as future liquidity needs will depend on fluctuations in levels of inventory, accounts receivable and accounts payable.
The following table sets forth, for the quarterly periods indicated,
certain of management’s key financial performance indicators:
(1)The sales cycle is calculated as the sum of days in accounts receivable and days in inventory, less the days in accounts payable; accordingly, the variance in the sales cycle quarter over quarter was a direct result of changes in these indicators.
(2)Inventory turns (annualized) are calculated as 360 days divided by days in inventory.
(3)Days in accounts receivable is calculated as accounts receivable, net, divided by net revenue multiplied by 90 days.
(4)Days in inventory is calculated as inventories, net and contract assets divided by cost of revenue multiplied by
90 days. During the three months ended February 28, 2023, the increase in days in inventory from the prior sequential quarter and the three months ended February 28, 2022, was primarily due to higher raw material balances related to supply chain constraints, particularly in the automotive supply chain.
(5)Days in accounts payable is calculated as accounts payable divided by cost of revenue multiplied by 90 days. During the three months ended February 28, 2023, the increase in days in accounts payable from the prior sequential quarter was primarily due to an increase in material purchases and timing of payments during the quarter. During the three months ended February 28, 2023, the decrease in days in accounts
payable from the three months ended February 28, 2022, was primarily due to cash payments and timing of purchases during the quarter.
Critical Accounting Policies and Estimates
The preparation of our Condensed Consolidated Financial Statements and related disclosures in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and assumptions based upon historical experience and various other factors and circumstances. Management believes that our
estimates and assumptions are reasonable under the circumstances; however, actual results may vary from these estimates and assumptions under different future circumstances. For further discussion of our
significant accounting policies, refer to Note 1 — “Description of Business and Summary of Significant Accounting Policies” to the Consolidated Financial Statements and “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates”
in our Annual Report on Form 10-K for the fiscal year ended August 31, 2022.
Recent Accounting Pronouncements
See Note 18 – “New Accounting Guidance” to the Condensed Consolidated Financial Statements for a discussion of recent accounting guidance.
Results of Operations
Net Revenue
Generally, we assess revenue on a global customer basis regardless of whether the growth is associated with organic growth or as a result of an acquisition. Accordingly, we do not
differentiate or separately report revenue increases generated by acquisitions as opposed to existing business. In addition, the added cost structures associated with our acquisitions have historically been relatively insignificant when compared to our overall cost structure.
The distribution of revenue across our segments has fluctuated, and will continue to fluctuate, as a result of numerous factors, including the following: fluctuations in customer demand; efforts to diversify certain portions of our business; business growth from new and existing customers; specific product performance; and any potential termination, or substantial winding down, of significant customer relationships.
Net revenue increased during the three months ended February 28, 2023, compared to the three months ended February 28, 2022. Specifically, the DMS segment net revenue increased 8% due to: (i) a 6% increase in revenues from existing customers within our automotive and transportation business, (ii) a 5% increase in revenues from existing customers within our mobility business, and (iii) a 4% increase in revenues from existing customers within our healthcare and packaging business. The increase is partially offset by a 7% decrease in revenues from existing customers within our connected devices business. The EMS segment net revenue increased 7% due to: (i) a 4% increase in revenues from existing customers within our industrial and capital equipment business, (ii) a 2% increase in revenues from
existing customers within our digital print and retail business, and (iii) a 2% increase in revenues from existing customers within our networking and storage business. The increase is partially offset by a 1% decrease in revenues from existing customers within our 5G, wireless and cloud business.
Net revenue increased during the six months ended February 28, 2023, compared to the six months ended February 28, 2022. Specifically, the EMS segment net revenue increased 13% due to: (i) a 4% increase in revenues from existing customers within our industrial and capital equipment business, (ii) a 4% increase in revenues from existing customers within our digital print and retail business, (iii) a 3% increase in revenues from existing customers within our networking and storage business, and (iv) a 2% increase in revenues from existing
customers within our 5G, wireless and cloud business. The DMS segment net revenue increased 8% due to: (i) a 7% increase in revenues from existing customers within our automotive and transportation business, (ii) a 4% increase in revenues from existing customers within our healthcare and packaging business, and (iii) a 1% increase in revenues from existing customers within our mobility business. The increase is partially offset by a 4% decrease in revenues from existing customers within our connected devices business.
We continue to expect $800 million in components that we procure and integrate for our cloud business will shift from a purchase and resale model to a customer-controlled consignment service model during fiscal year 2023. As a result of this continued transition, revenue associated with these components are shown on a net basis and as a result, we expect higher gross margins and lower cash used in this business.
Gross profit as a percentage of net revenue remained relatively consistent for the three months and six months ended February 28, 2023, compared to the three months and six months ended February 28, 2022.
Selling, general and administrative expenses increased during the three months ended February 28, 2023, compared to the three months ended February 28, 2022. The increase is primarily due to a $4 million increase in stock-based compensation expense due to awards granted during the three months ended November 30, 2022.
Selling, general and administrative expenses increased during the six months ended February 28, 2023, compared to the six months ended February 28, 2022. The increase is primarily due to a $11 million increase in stock-based compensation expense due to higher anticipated achievement levels for
certain performance-based stock awards and awards granted during the three months ended November 30, 2022.
Research and development expenses remained consistent as a percentage of net revenue during the three months and six months ended February 28, 2023, compared to the three months and six months ended February 28, 2022.
Amortization of intangibles remained relatively consistent during the three months and six months ended February 28, 2023, compared to the three months and six months ended February 28, 2022.
Restructuring, severance and related charges increased during the six months ended February 28, 2023, compared to the six months ended February 28, 2022 primarily related to a headcount reduction to further optimize our business activities during the three months ended November 30, 2022.
The change in other expense (income) during the three months ended February 28, 2023, compared to the three months ended February 28, 2022, is primarily due to: (i) $15 million related to an increase in fees associated with the securitization programs and higher utilization of and higher interest rates for the trade accounts receivable sales programs, (ii) $4 million primarily related to higher net periodic benefit costs, and (iii) $2 million arising from an increase in other expense.
The change in other expense (income) during the six months ended February 28, 2023, compared to the six months ended February 28, 2022, is primarily due to: (i) $31 million
related to an increase in fees associated with the securitization programs and higher utilization of and higher interest rates for the trade accounts receivable programs, and (ii) $7 million primarily related to higher net periodic benefit costs. The change is partially offset by $3 million arising from a decrease in other expense.
Interest income increased during the three months and six months ended February 28, 2023, compared to the three months and six months ended February 28, 2022, primarily due to higher interest rates on cash equivalents (investments that are readily convertible to cash with maturity dates of 90 days or less).
Interest expense increased during the three months and six months ended February 28, 2023, compared to the three months and six months ended February 28, 2022, primarily due to higher interest rates on our commercial paper program and credit facilities.
The effective income tax rate differed for the three months and six months ended February 28, 2023, compared to the three months and six months ended February 28, 2022, primarily due to: (i) a change in the jurisdictional mix of earnings, driven in part by restructuring charges for the six months ended February 28, 2023 and (ii) a $10 million income tax benefit associated with the reversal of a non-U.S. partial valuation allowance during the three months ended February 28, 2023.
The following discussion and analysis of our financial condition and results of operations include certain non-GAAP financial measures as identified in the reconciliations below. The non-GAAP financial measures disclosed herein do not have standard meaning and may vary from the non-GAAP financial measures used by other companies or how we may calculate those measures in other instances from time to time. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with U.S. GAAP. Among other uses, management uses non-GAAP “core” financial measures to make operating decisions, assess business performance and as a factor in determining certain
employee performance when evaluating incentive compensation. Also, our “core” financial measures should not be construed as an indication by us that our future results will be unaffected by those items that are excluded from our “core” financial measures.
For fiscal year 2023, the Company adopted an annual normalized tax rate (“normalized core tax rate”) for the computation of the non-GAAP (core) income tax provision to provide better consistency across reporting periods. In estimating the normalized core tax rate annually, the Company utilizes a full-year financial projection of core earnings that considers the mix of earnings across tax jurisdictions, existing tax positions, and other significant tax matters. The
Company may adjust the normalized core tax rate during the year for material impacts from new tax legislation or material changes to the Company’s operations.
Prior to fiscal year 2023, the Company determined the tax effect of the items included and excluded from core earnings quarterly.
Included in the tables below are reconciliations of the non-GAAP financial measures to the most directly comparable U.S. GAAP financial measures as provided in our Condensed Consolidated Financial Statements:
Reconciliation of U.S. GAAP Financial Results to Non-GAAP Measures
Stock-based compensation expense and related charges
20
16
62
51
Restructuring, severance and related charges(1)
—
—
45
—
Net periodic benefit cost(2)
3
7
7
14
Adjustments to operating income
32
31
131
81
Core operating income (Non-GAAP)
$
391
$
344
$
852
$
744
Net income attributable to Jabil Inc. (U.S. GAAP)
$
207
$
222
$
430
$
463
Adjustments to operating income
32
31
131
81
Net periodic benefit cost(2)
(3)
(7)
(7)
(14)
Adjustments for taxes
20
—
21
—
Core earnings (Non-GAAP)
$
256
$
246
$
575
$
530
Diluted earnings per share (U.S. GAAP)
$
1.52
$
1.51
$
3.14
$
3.15
Diluted core earnings per share (Non-GAAP)
$
1.88
$
1.68
$
4.19
$
3.60
Diluted weighted average shares outstanding (U.S. GAAP and Non-GAAP)
136.3
146.4
137.1
147.0
(1)Recorded during the six months ended February 28, 2023, related to headcount reduction to further optimize our business activities.
(2)We are reclassifying the pension components in other expense to core operating income as we assess operating performance, inclusive of all components of net periodic benefit cost, with the related revenue. There is no impact to core earnings or diluted core earnings per share for this adjustment.
Net cash provided by operating activities (U.S. GAAP)
$
580
$
200
Acquisition of property, plant and equipment (“PP&E”)(1)
(637)
(704)
Proceeds and advances from sale of PP&E(1)
169
430
Adjusted free cash flow (Non-GAAP)
$
112
$
(74)
(1)Certain customers co-invest in property, plant and equipment (“PP&E”) with us. As we acquire PP&E, we recognize the cash payments in acquisition of PP&E. When our customers reimburse us and obtain control, we recognized the cash receipts in proceeds and advances from the sale of PP&E.
Liquidity and Capital Resources
We believe that our level of liquidity sources, which includes cash on hand, available borrowings under our revolving credit facilities and commercial paper program, additional proceeds available under our global asset-backed securitization program and under our uncommitted trade accounts receivable sale programs, cash flows
provided by operating activities and access to the capital markets, will be adequate to fund our capital expenditures, the payment of any declared quarterly dividends, any share repurchases under the approved programs, any potential acquisitions, our working capital requirements and our contractual obligations for the next 12 months and beyond. We continue to assess our capital structure and evaluate the merits of redeploying available cash.
Cash and Cash Equivalents
As of February 28, 2023, we had approximately $1.2 billion in cash and cash equivalents, of which a significant portion was held by our foreign subsidiaries. Most of our foreign cash and cash equivalents as of February 28, 2023
could be repatriated to the United States without potential tax expense.
Notes Payable and Credit Facilities
Following is a summary of principal debt payments and debt issuance for our notes payable and credit facilities:
(1)On February 10, 2023, we entered into an amendment (the “Amendment”) to our senior unsecured credit agreement dated as of January 22, 2020 (as amended, the “Credit Facility”). The Amendment, among other things, (i) instituted certain amendments to the sustainability-linked adjustments to the interest rates applicable to borrowings under the three-year revolving credit facility (the “Three-Year Revolving Credit Facility”) and the five-year revolving credit facility (the “Five-Year Revolving Credit Facility”), (ii) established customary SOFR, CDOR, EURIBOR and TIBOR provisions, which replaced the LIBOR provisions set forth in the existing agreement, and (iii) extended the termination date of the Three-Year Revolving Credit Facility to January
22, 2025, and of the Five-Year Revolving Credit Facility to January 22, 2027.
(2)As of February 28, 2023, we had $3.8 billion in available unused borrowing capacity under our revolving credit facilities. The Credit Facility acts as the back-up facility for commercial paper outstanding, if any. We have a borrowing capacity of up to $3.2 billion under our commercial paper program. Commercial paper borrowings with an original maturity
of 90 days or less are recorded net within the Condensed Consolidated Statements of Cash Flows, and have been excluded from the table above.
We have a shelf registration statement with the SEC registering the potential sale of an indeterminate amount of debt and equity securities in the future to augment our liquidity and capital resources.
Our Senior Notes and our credit facilities contain various financial and nonfinancial covenants. A violation of these covenants could negatively impact our liquidity by restricting our ability to borrow under the notes payable and credit facilities and potentially causing acceleration of amounts due under these notes payable and credit facilities. As of February 28, 2023 and August 31, 2022, we were in compliance with our debt covenants. Refer
to Note 5 – “Notes Payable and Long-Term Debt” to the Condensed Consolidated Financial Statements for further details.
Global Asset-Backed Securitization Program
Certain Jabil entities participating in the global asset-backed securitization program continuously sell designated pools of trade accounts receivable to a special purpose entity, which in turn sells certain of the receivables at a discount to conduits administered by an unaffiliated financial institution on a monthly basis. In addition, a foreign entity participating in the global asset-backed securitization program sells certain receivables at a discount to conduits administered by an unaffiliated financial institution on a daily basis.
We continue servicing the receivables sold and in exchange receive a servicing fee under the global asset-backed securitization program.
Servicing fees related to the global asset-backed securitization program recognized during the three months and six months ended February 28, 2023 and 2022 were not material. We do not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as we estimate that the fee we receive to service these receivables approximates the fair market compensation to provide the servicing activities.
The special purpose entity in the global asset-backed securitization program is a wholly-owned subsidiary of the Company and is included in our Condensed Consolidated Financial Statements. Certain unsold receivables covering up to the maximum amount of net cash proceeds available under the domestic, or U.S., portion of the global asset-backed
securitization program are pledged as collateral to the unaffiliated financial institution as of February 28, 2023.
The global asset-backed securitization program expires on November 25, 2024 and the maximum amount of net cash proceeds available at any one time is $600 million. During the three months and six months ended February 28, 2023, we sold $1.0 billion and $2.1 billion, respectively, of trade accounts receivable and we received cash proceeds of $1.0 billion and $2.0 billion, respectively. As of February 28, 2023, we had no available liquidity under our global asset-backed securitization program.
The global asset-backed securitization program requires compliance with several covenants including compliance with the interest ratio and debt to EBITDA ratio of the Credit Facility. As of February 28, 2023 and August 31, 2022, we were in compliance with all covenants under our global asset-backed securitization program. Refer to Note 6 – “Asset-Backed Securitization Program” to the Condensed Consolidated Financial Statements for further details on the program.
Trade Accounts Receivable Sale Programs
As of February 28, 2023, we may elect to sell receivables and the unaffiliated financial institutions
may elect to purchase specific accounts receivable at any one time up to a: (i) maximum aggregate amount available of $2.1 billion under nine trade accounts receivable sale programs, (ii) maximum amount available of 400 million CNY under one trade accounts receivable sale program and (iii) maximum amount available of 100 million CHF under one trade accounts receivable sale program. The trade accounts receivable sale programs expire on various dates through 2025.
During the three months and six months ended February 28, 2023, we sold $2.9 billion and $6.5 billion, respectively, of trade accounts receivable under these programs and we received cash proceeds of $2.9 billion and $6.4 billion, respectively. As of February 28, 2023, we had up to $1.3 billion in available liquidity under our trade accounts receivable sale programs.
Effect of exchange rate changes on cash and cash equivalents
(3)
(1)
Net decrease in cash and cash equivalents
$
(278)
$
(474)
Operating Activities
Net cash provided by operating activities during the six months ended February 28, 2023, was primarily due to non-cash expenses and net income and a decrease in accounts receivable, accounts payable, accrued expenses and other liabilities, contract assets. These decreases were partially offset by an increase in inventories and prepaid expenses and other current assets. The decrease in accounts receivable is primarily driven by the timing of collections. The decrease in accounts payable, accrued expenses and other liabilities is primarily due to the timing of purchases and cash payments. The decrease in contract
assets is primarily due to timing of revenue recognition for over time customers. The increase in inventories is primarily due to higher raw material balances related to supply chain constraints, particularly in the automotive supply chain. The increase in prepaid expenses and other current assets is primarily due to the timing of payments.
Investing Activities
Net cash used in investing activities during the six months ended February 28, 2023 consisted primarily of capital expenditures, principally to support ongoing business in the DMS and EMS segments, partially offset by proceeds and advances from the sale of property, plant and equipment.
Financing Activities
Net cash used in financing activities during the six months ended February
28, 2023 was primarily due to (i) payments for debt agreements, (ii) the repurchase of our common stock under our share repurchase authorization, (iii) the purchase of treasury stock under employee stock plans, and (iv) dividend payments. Net cash used in financing activities was partially offset by borrowings under debt agreements.
Capital Expenditures
For Fiscal Year 2023, we anticipate our net capital expenditures will be approximately $875 million. In general, our capital expenditures support ongoing maintenance in our DMS and EMS segments and investments in capabilities and targeted end markets. The amount of actual capital expenditures may be affected by general economic, financial, competitive, legislative and regulatory factors, among other things.
Dividends and Share Repurchases
We
currently expect to continue to declare and pay regular quarterly dividends of an amount similar to our past declarations. However, the declaration and payment of future dividends are discretionary and will be subject to determination by our Board of Directors each quarter following its review of our financial performance and global economic conditions.
In July 2021, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of our common stock (the “2022 Share Repurchase Program”). As of February 28, 2023, 16.5 million shares had been repurchased for $1.0 billion and no authorization remains under the 2022 Share Repurchase Program.
In September 2022, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the
Company’s common stock (the “2023 Share Repurchase Program”). As of February 28, 2023, 0.3 million shares had been repurchased for $25 million and $975 million remains available under the 2023 Share Repurchase Program.
As of the date of this report, other than the new operating and finance leases, (see Note 4 – “Leases” to the Condensed Consolidated Financial Statements), there were no material changes outside the ordinary
course of business, since August 31, 2022, to our contractual obligations and commitments and the related cash requirements.
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in our primary risk exposures or management of market risks from those disclosed in our Annual Report on Form 10-K for the fiscal year ended August 31, 2022.
Item 4.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We carried out an evaluation required by Rules 13a-15 and 15d-15 under the Exchange Act (the “Evaluation”), under the supervision and with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15 and 15d-15 under the Exchange Act as of February 28, 2023. Based on the Evaluation, our CEO and CFO concluded that the design and operation of our disclosure controls were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods
specified in SEC rules and forms, and (ii) accumulated and communicated to our senior management, including our CEO and CFO, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
For our fiscal quarter ended February 28, 2023, we did not identify any modifications to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
See the discussion in Note 17 - “Commitments and Contingencies” to the Condensed Consolidated Financial Statements.
Item 1A.
Risk Factors
For information regarding risk factors that could affect our business, results of operations, financial condition or future results, see Part I, “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended August 31, 2022. For further information on our forward-looking statements see Part I of this Quarterly Report on Form 10-Q.
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
The following table provides information relating to our repurchase of common stock during the three months ended February 28, 2023:
(1)The purchases include amounts that are attributable to 47,242 shares surrendered to us by employees to satisfy, in connection with the vesting of restricted stock unit awards, their tax withholding obligations.
(2)In July 2021, our Board of Directors authorized the repurchase of up to $1.0 billion of our common stock as publicly announced in a press release on July 23, 2021 (the “2022 Share Repurchase Program”). No authorization remains under the 2022 Share Repurchase Program as of February 28, 2023.
(3)In September 2022, our Board
of Directors authorized the repurchase of up to $1.0 billion of our common stock as publicly announced in a press release on September 27, 2022 (the “2023 Share Repurchase Program”).
The following financial information from Jabil’s Quarterly Report on Form 10-Q for the quarterly period ended February 28, 2023, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets as of February 28, 2023 and August 31, 2022, (ii) Condensed Consolidated Statements of Operations for the three months and six months ended February 28, 2023 and 2022, (iii) Condensed Consolidated Statements of Comprehensive Income for the three months and six months ended February 28, 2023 and 2022, (iv) Condensed Consolidated Statements of Stockholders’ Equity for the three months and
six months ended February 28, 2023 and 2022, (v) Condensed Consolidated Statements of Cash Flows for the six months ended February 28, 2023 and 2022, and (vi) the Notes to Condensed Consolidated Financial Statements.
104
Cover Page Interactive Data File (Embedded within the inline XBRL Document in Exhibit 101).
Certain instruments with respect to long-term debt of the Registrant and its consolidated subsidiaries are not filed herewith pursuant to Item 601(b)(4)(iii) of Regulation S-K since the total amount of securities authorized under each such instrument does not exceed 10% of the total assets of the
Registrant and its subsidiaries on a consolidated basis. The Registrant agrees to furnish a copy of any such instrument to the Securities and Exchange Commission upon request.
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.